Effective treatments are required for patients with diffuse large B‐cell lymphoma (DLBCL) with primary refractory disease. (June 2017)

Record Type:: Journal Article
Title:: Effective treatments are required for patients with diffuse large B‐cell lymphoma (DLBCL) with primary refractory disease. (June 2017)
Main Title:: Effective treatments are required for patients with diffuse large B‐cell lymphoma (DLBCL) with primary refractory disease
Authors:: Salas, Q.Q.
Domingo Domenech, E.
Mercadal, S.
Oliveira, A.
Aguilera, C.
De la Banda, E.
Climent, F.
Lucas, A.
Garcia, N.
Baca, C.
Fernandez de Sevilla, A.
Sureda, A.
González Barca, E.
Abstract:
Is Part Of:: Hematological oncology. Volume 35(2017)Supplement 2
Journal:: Hematological oncology
Issue:: Volume 35(2017)Supplement 2
Issue Display:: Volume 35, Issue 2 (2017)
Year:: 2017
Volume:: 35
Issue:: 2
Issue Sort Value:: 2017-0035-0002-0000
Page Start:: 344
Page End:: 344
Publication Date:: 2017-06
Subjects:: Hematological oncology -- Periodicals
Hematology
Medical Oncology
616.99418005
Journal URLs:: http://onlinelibrary.wiley.com/ ↗
DOI:: 10.1002/hon.2439_92 ↗
Languages:: English
ISSNs:: 0278-0232
Deposit Type:: Legaldeposit
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗
Physical Locations:: British Library DSC - 4291.550000
British Library DSC - BLDSS-3PM
British Library STI - ELD Digital store
Ingest File:: 1268.xml